Protective mechanism of APOE3‐Christchurch in Alzheimer’s disease
Ana‐Caroline Raulin, Cynthia Linares, Alla Alnobani, Bhaskar Roy, Ailsa Crow, Sydney V Doss, Lindsey A Kuchenbecker, Maxwell V Dacquel, Celeste M Karch, Yuka A Martens, Chia‐Chen Liu, Guojun Bu, Takahisa Kanekiyo · 2025
Read Protective mechanism of APOE3‐Christchurch in Alzheimer’s disease by Ana‐Caroline Raulin, Cynthia Linares, Alla Alnobani, Bhaskar Roy, Ailsa Crow, Sydney V Doss, Lindsey A Kuchenbecker, Maxwell V Dacquel, Celeste M Karch, Yuka A Martens, Chia‐Chen Liu, Guojun Bu, Takahisa Kanekiyo (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712626.txt.
Description
A research team probes in 2025 how a rare gene form shields the brain from Alzheimer disease. Two copies of the APOE3-Christchurch form held off an aggressive family form of the disease by about 30 years in one known case. Mouse and stem cell models test how the shield works.
In mice, the form cut loose amyloid clumps and eased cell stress in older brains. Lab-made forms of the protein bound heparin less, gripped targets in new ways, and took up fats better. Stem cell brain models also split by form, which may point to new drug paths.
Catalog record
| CREATOR | Ana‐Caroline Raulin, Cynthia Linares, Alla Alnobani, Bhaskar Roy, Ailsa Crow, Sydney V Doss, Lindsey A Kuchenbecker, Maxwell V Dacquel, Celeste M Karch, Yuka A Martens, Chia‐Chen Liu, Guojun Bu, Takahisa Kanekiyo |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |